• No results found

zoledronic acid

 FORMULATION AND EVALUATION OF ZOLEDRONIC ACID FOR INJECTION BY LYOPHILIZATION TECHNIQUE

 FORMULATION AND EVALUATION OF ZOLEDRONIC ACID FOR INJECTION BY LYOPHILIZATION TECHNIQUE

... of zoledronic acid, mannitol used as lyophilisation aid, sodium citrate as buffering agent and water for injection as ...lyophilized zoledronic acid injection for same solvent used for ...

7

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

... and zoledronic acid (Zometa®), induce apoptosis in osteoclasts by inhibiting enzymes of the mevalonate pathway and preventing the isoprenylation of small GTP-binding proteins such as Ras and Rho (Hughes et ...

9

DEVELOPMENT, EVALUATION AND STABILITY OF ZOLEDRONIC ACID I.V INJECTION BY LYOPHILIZATION TECHNIQUERajesh Akki*, M.Gayatri Ramya ,M.Hymavathi, P.Dinesh KumarDOWNLOAD/VIEW

DEVELOPMENT, EVALUATION AND STABILITY OF ZOLEDRONIC ACID I.V INJECTION BY LYOPHILIZATION TECHNIQUERajesh Akki*, M.Gayatri Ramya ,M.Hymavathi, P.Dinesh KumarDOWNLOAD/VIEW

... Zoledronic acid is an nitrogen containing bisphosphonates and, like the other molecules of this class, binds to hydroxyapatite in the bone mineral matrix and strongly inhibits bone ...pyrophosphate[1]. ...

5

Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report

Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report

... Conclusions: This is the first report of zoledronic acid induced uveitis with macular edema after long-term alendronate tolerance. Prior oral alendronate may not entirely prevent ZAIU. Steroids are usually ...

5

Protocol for a randomised control trial of bisphosphonate (zoledronic acid) treatment in childhood femoral head avascular necrosis due to Perthes disease

Protocol for a randomised control trial of bisphosphonate (zoledronic acid) treatment in childhood femoral head avascular necrosis due to Perthes disease

... bisphosphonate zoledronic acid (ZA) to inhibit osteoclastic bone resorption is aimed at preserving femoral head strength, reducing collapse and thus maintaining ...

8

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis

... loss of TSC2 gene. The TSC2 protein can form a com- plex with GTPase Rheb to block the activity of mTORC1, thus inhibiting the mTOR pathway [10]. Hence, the loss function mutation of TSC2 gene in LAM patients causes the ...

11

The Role of Health Education in Improving Patient Compliance with Zoledronic Acid

The Role of Health Education in Improving Patient Compliance with Zoledronic Acid

... of Zoledronic Acid injections in each group during the three ...of Zoledronic Acid treatment, it is obvious that the patients who have participated in more than two health education activities ...

8

Optimization of Dose and Imaging Time for 99mTc Zoledronic Acid for Osteoscintigraphy

Optimization of Dose and Imaging Time for 99mTc Zoledronic Acid for Osteoscintigraphy

... 99mTcO -4 is procured in the form of 99Mo/99mTc Generator from Paras Isotope, Iran. Zoledronic Acid kit was a kind of gift from Sanlar Imex, Mumbai. Other chemicals of high and analytical grade were used ...

9

Zoledronic acid exacerbates inflammation through M1 macrophage polarization

Zoledronic acid exacerbates inflammation through M1 macrophage polarization

... ribonucleic acid; NLRP3: Nod-like receptor 3; PBS: Phosphate- buffered saline; PMA: Phorbol 12-myristate 13-acetate; RT-PCR: Reverse transcription-polymerase chain reaction; Zol: Zoledronic ...

8

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management

... days of surgical repair of a hip fracture, participants received 5 mg of intravenous zoledronic acid or placebo. At 36 months, they had significantly increased BMD at the total hip and femoral neck compared ...

17

Osteoporosis in chronic spinal cord injury and the effect of zoledronic acid

Osteoporosis in chronic spinal cord injury and the effect of zoledronic acid

... Zoledronic acid (1-hydroxy-2-imidazole-1-yl-1-phosphono-ethyl phosphonic acid), a newer and more potent bisphosphonate, belongs to a new class of highly potent nitrogen containing ...bisphosphonates. ...

102

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture

... Patients at risk of hip fracture are generally elderly, over 75. So, the tolerability of drugs is essential in this frail population. In the HORIZON Pivotal Fracture Trial, 2.3% of women had hypocalcemia, defi ned as ...

8

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

... that zoledronic acid provides a statistically significant improve- ment in BMD at 1 ...receive zoledronic acid were three to five times more likely to experience a clinically meaningful loss ...

8

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol

Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol

... of zoledronic acid, (b) equal and greater or less than the median of IFN-γ at 5 hours after the administration of zoledronic acid and (c) presence of fever and/or flu-like symptoms, are ...of ...

6

The effectiveness of zoledronic acid and ibandronic acid as therapy for bone metastases in multiple myeloma: A systematic review

The effectiveness of zoledronic acid and ibandronic acid as therapy for bone metastases in multiple myeloma: A systematic review

... Zoledronic acid and ibandronic acid are used in preventing skeletal-related event (SRE) in multiple myeloma ...intravenous zoledronic and ibandronic acids in preventing ...of zoledronic ...

8

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis

... with Zoledronic Acid Once Yearly-Pivotal Fracture Trial; HORIZON-RFT, The Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly-Recurrent Fracture Trial; IV, intravenous; LTO, ...

15

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

... Bisphosphonates, a family of drugs that have been widely used as bone resorption inhibitors for osteopor- osis for decades [10], inhibit calcium hydroxyphosphate dissolution and osteolysis [11]. Recently, a third gener- ...

7

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid

... (+1.2% vs -6.7%, respectively; P , 0.001) Abbreviations: BMD, bone mineral density; CLO, clodronate; CTIBL, cancer therapy induced bone loss; FN, femoral neck; Iv, intravenous; LS, lumbar spine; mo, months; N, number; P, ...

8

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

... intravenous zoledronic acid offers the potential to improve effectiveness in clinical practice by providing 100% bioavailability, eliminating concern of malabsorption of oral bisphosphonates due to ...

11

Determination of Zoledronic Acid and Four Common Anions in Zoledronic Acid Injection by Gradient Ion Chromatography with a Self Regeneration Suppressor

Determination of Zoledronic Acid and Four Common Anions in Zoledronic Acid Injection by Gradient Ion Chromatography with a Self Regeneration Suppressor

... of zoledronic acid injection (purchased from local drug shop) was transfer into a 100 mL volumetric flask and diluted to 100 mL with deionized water, which was shaked thoroughly, and then centrifuged for 5 ...

5

Show all 10000 documents...

Related subjects